Publications in press

Bergman AM, Adema AD, Balzarini J, Bruheim S, Fichtner I, Noordhuis P, Fodstad O, Myhren F, Sandvold ML, Hendriks HR, Peters GJ
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
Invest New Drugs (in press)
PubMed 20066470

Publications 2009

Bruheim S, Xi Y, Ju J, Fodstad O (2009)
Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide
Clin Cancer Res, 15 (23), 7161-9
PubMed 19920113

Hoyem S, Bruheim S, Maelandsmo G, Standal M, Olberg DE, Brudeli B, Asberg A, Klaveness J, Rongved P (2009)
Didanosine ester prodrugs: Synthesis, albumin binding properties and pharmacokinetic studies in rats (vol 44, pg 3874, 2009)
Eur. J. Med. Chem., 44 (11), 4786

Høyem S, Bruheim S, Maelandsmo G, Olberg DE, Brudeli B, Asberg A, Klaveness J, Rongved P (2009)
Didanosine ester prodrugs: synthesis, albumin binding properties and pharmacokinetic studies in rats
Eur J Med Chem, 44 (10), 3874-9
PubMed 19433342

Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, Fodstad O, Ju J (2009)
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
Oncogene, 28 (46), 4065-74
PubMed 19734943

Publications 2008

Nakajima G, Patino-Garcia A, Bruheim S, Xi Y, San Julian M, Lecanda F, Sierrasesumaga L, Müller C, Fodstad O, Ju J (2008)
CDH11 expression is associated with survival in patients with osteosarcoma
Cancer Genomics Proteomics, 5 (1), 37-42
PubMed 18359978

Publications 2005

Matsumoto T, Bohman S, Dixelius J, Berge T, Dimberg A, Magnusson P, Wang L, Wikner C, Qi JH, Wernstedt C, Wu J, Bruheim S, Mugishima H, Mukhopadhyay D, Spurkland A, Claesson-Welsh L (2005)
VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis
EMBO J, 24 (13), 2342-53
PubMed 15962004

Publications 2004

Bruheim S, Bruland OS, Breistol K, Maelandsmo GM, Fodstad O (2004)
Human osteosarcoma xenografts and their sensitivity to chemotherapy
Pathol Oncol Res, 10 (3), 133-41
PubMed 15448748

Publications 2003

Bruheim S, Krobert KA, Andressen KW, Levy FO (2003)
Unaltered agonist potency upon inducible 5-HT7(a) but not 5-HT4(b) receptor expression indicates agonist-independent association of 5-HT7(a) receptor and Gs
Receptors Channels, 9 (2), 107-16
PubMed 12916471